SUMMARY -Children with atopic dermatitis (AD) usually develop symptoms when they reach the age of 6-7 years, but the risk of developing respiratory allergies, asthma and allergic rhinitis (AR) remains high. In most children with AD, the development of asthma and AR is associated with sensitization to food allergens and/or aeroallergens, while only a small percentage missed atopic diathesis. In about 35% of children with AD, food allergy is the provoking cause, and 60% of infants who had AD in the fi rst 3 months of life were sensitized against aeroallergens by the age of 5. Th e aim of the study was to follow development of asthma and AR and to assess the most signifi cant risk factors for developing respiratory allergy. A total of 114 children with AD were followed up for fi ve years. At annual visits, the severity of disease, total immunoglobulin E (IgE) antibody values, skin prick tests, specifi c IgE antibodies to food allergens and aeroallergens, and absolute eosinophil count were assessed. Information on the family history of atopy and AD, feeding patterns during infancy, data on sensitivity to food allergens and/or aeroallergens, and on the occurrence of bronchial obstruction and nose symptoms were obtained. Asthma developed in 36 children, median age 7.7 years; 33 children had symptoms of AR, and 13 children with AD had both diseases associated; 38 children had sensitivity to food, of which 24 developed asthma and 13 AR; asthma developed in 18/23 children with sensitivity to aeroallergens, and almost an equal number of children developed AR. Th e increased absolute eosinophil count and specifi c IgE to aeroallergens and food allergens were the best asthma predictors, while AR predictors were family history and early onset of AD. In conclusion, children with AD are at a signifi cant risk of developing respiratory allergies, and those with the increased absolute eosinophil count, positive specifi c IgE to aeroallergens and food allergens, heredity of AD, and early onset of AD are at the highest risk. Identifi cation of risk factors will enable us to improve the treatments of AD in order to reduce the severity of disease and prevent manifestation of respiratory allergy.
Introduction
Atopic dermatitis (AD) is one of the most common chronic infl ammatory skin diseases in children, with the highest incidence during the fi rst three months of life, and up to 85% of children suff er from AD before 5 years of age 1 . Th e prognosis of AD is usually good, but the risk of developing asthma and allergic rhinitis (AR) is very high 2 . Up to 80% of children with AD will develop some allergic respiratory disease; in about 50% of children it manifests as asthma 3 . Clinical experience shows the risk to be approximately 70% in children with severe form, about 30% of children with moderate form, and only children with mild AD will not develop either asthma or AR 4, 5 . In most children with AD, the development of asthma and AR is associated with sensitization to food allergens and/or aeroallergens, increased serum immunoglobulin E (IgE) antibodies, while only a low percentage will miss atopic diathesis 6 . Commonly, AD and food allergy coexist in children with AD, while in about 35% of children with AD food allergy is the provoking cause 7 . About 69% of infants who had AD during the fi rst 3 months of life were sensitized against aeroallergens by the age of 5 years 8 . Th e aim of the study was to monitor the development of asthma and AR in children with AD and observe the most signifi cant risk factors for developing respiratory allergies.
Patients and Methods
A prospective cross-sectional study was conducted at the Clinical Department for Children's Diseases, Tuzla University Clinical Center (UCC), during the period from January 2010 to January 2015. Th e inclusion criteria were satisfying at least three major and three minor criteria according to the Hanifi n and Rajka diagnostic criteria for AD 9 , and duration of the pruritic skin changes of at least 3 months. Th e children were examined once a year for the next fi ve years; the severity of disease was assessed, and total IgE antibody values, skin prick tests (SPTs) and specifi c IgE antibodies to food allergens and aeroallergens were determined. Bronchial asthma was defi ned as three or more episodes of bronchial obstruction diagnosed by a physician. Allergic rhinitis was defi ned as development of rhinitis at least twice after exposure to a particular allergen and unrelated to infection. Urticaria was defi ned as the history of typical symptoms. Atopic heredity was regarded as present if at least one of the family members had shown symptoms of AD, bronchial asthma, or AR. At the fi rst visit, a questionnaire was fi lled out including information about the age and sex of children, age of the child when the fi rst signs of AD appeared, severity of the disease, background factors such as heredity of atopy and AD, symptoms of bronchial obstruction, feeding patterns during infancy, other possible allergic symptoms, and data on sensitivity to food allergens and/or aeroallergens. At the follow-up visits, a written form based on an interview was fi lled out containing questions about exposures and events since the last visit: furry animals at home, exposure to tobacco smoke, occurrence of bronchial obstruction, and rhinitis. Th e exclusion criteria were failing to meet the diagnostic criteria, duration of pruritic skin changes of less than 3 months, acute and/ or chronic disease with no atopic basis, an associated systemic disorder, and the parents' refusal to enroll their child in the study. All background factors are listed in Table 1 .
Th e SCORing Atopic Dermatitis (SCORAD) index 10 was used to assess the severity of disease. We assessed the following (Table 2) : (A) spread of skin changes, expressed in a range of 0-100; (B) intensity of skin changes graded on a 0-3 scale, where 0 indicated absence of changes, 1 minor changes, 2 moderate changes, and 3 intense changes; (C) subjective signs were presented on a 1-10 scale, where 0 signifi es "never better" and 10 "never worse". Th e child (if it was an older child over 5 years of age) or the child's caretaker expressed an opinion on the intensity of subjective signs.
Th e values of the SCORAD index were calculated according to the formula A/5+7B/2+C. Th e maximum SCORAD index value was 103. According to the SCORAD index values, the severity of the disease was Blood for determination of total IgE antibody values and specifi c IgE antibodies to food allergens and/or aeroallergens was obtained by the standard procedure and analyzed at the Polyclinic for Laboratory Diagnosis, Immunology Department, Tuzla UCC. Blood samples were centrifuged at 2000 rpm for 10 minutes. To determine total IgE antibodies, the samples were analyzed within 24 hours by immunonephelometry (Nephelometer Dade Behring, Marburg, Germany). Total IgE antibody values of 0-100 IU/mL were considered normal. Th e separated serum was stored at -80 °C until used to determine specifi c IgE antibodies to food allergens and/or aeroallergens (the most common allergens: cow's milk, eggs, fl our, soya, peanuts and fi sh; house dust, Dermatophagoides pteronyssinus, animal hair-fur, grass pollen and weed pollen), allergens for which the children had positive SPTs, and allergens suspected to be responsible for sensitivity based on medical history. Testing was performed using the ELISA method (Enzyme Linked ImmunoSorbent Assay; Hy Tec 288 Plus apparatus, Agilent Technologies Company, Biomedical, Garden Grove, Ca, United States). Th e values >0.35 IU/ mL were considered positive.
Th is study was approved by the Ethics Committee of the Tuzla University Clinical Center in Tuzla. Th e informed consent form was signed by the participants' parents.
Statistical data analysis was performed using MedCalc for Windows, version 15.11.4 (MedCalc Software, Ostend, Belgium). Numerical data and variables with distorted distribution were expressed by median as a measure of central value and interquartile range, while c 2 -test contingency was used to analyze diff erentiation in the frequency of the parameters analyzed. Two-sided p value <0.05 was considered signifi cant. To identify the factors that best predicted the outcome parameter, asthma and AR development, logistic regression was used. Th e selection method was the backward stepwise elimination with likelihood ratio.
Results
Th e study criteria included 114 children with AD (56 boys and 58 girls), median age on admission to the study 26.5 months, minimum 1.5 and maximum 96 months; by the end of the study, the children were (Table 3) ; the median SCORAD index was 28.5 points at the fi rst visit, but was lower (21.6 points) at the end of the study.
At the last visit, skin changes almost disappeared in 11 children (SCORAD 5 points) while in 9 children it was only 6. Th e results of examinations and the history of visits are shown in Table 4 . At the fi rst visit, 43 children had adverse food reactions, whereas at the end of the study sensitivity to one or more food allergens was found in 38 children. While manifestation and/or worsening of nasal symptoms and/or skin changes after exposure to aeroallergens was recorded in 26 children, sensitivity (positive SPTs and/or specifi c IgE) to one or more aeroallergens was found in 23 of these children. However, 8 children exhibited sensitivity to more than one allergen (food allergens and aeroallergens) by the end of the study. We found positive specifi c IgE to the following allergens: cow's milk, hen's egg, fruit (group I), vegetable (group II), meat, fi sh, soybean, chocolate, and house dust, Dermatophagoides pteronyssinus, pollen from grass, weed, tree, animal hair-fur, and feather. Positive SPT fi ndings and specifi c IgE to food allergens and aeroallergens are shown in Table 5 .
At the fi rst visit, 51 children, median age 16.7 months, had symptoms of bronchial obstruction (Table 4), although at the follow-up visits 31 of them were asymptomatic and 16 had obstructive symptoms by Table 6 ). Fifteen of these children had the severe form of AD (at least twice at annual visits), an almost equal number of children (n=14) had the moderate form, and 7 children developed asthma although they had the mild form of AD. However, 13 children (9 and 4 children with the moderate and severe form of AD, respectively) developed associated asthma and AR. Comparative data between children who developed asthma and children who developed AR according to explanatory factors are shown in Table 7 .
A signifi cantly high risk of developing both diseases was found for heredity of atopy and AD, early onset, severe form of AD, increased values of total IgE antibodies, positive SPTs and specifi c IgE to food allergens and aeroallergens. However, multivariate analysis with relevant factors for asthma showed the increased absolute eosinophil count and positive specifi c IgE to aeroallergens and food allergens to be significant factors; for AR, family history of AD and AD onset before 4 months were signifi cant factors too (Table 8) .
Discussion
Th e nature of the relationship between AD, asthma and AR has been controversial. It has been commonly held that these disorders, while sharing genetic and environmental risk factors, are unrelated disorders that may develop sequentially along an atopic pathway. Conversely, the link between eczema and these lateronset respiratory disorders may be causal 11 . However, many studies suggest the signifi cant risk of developing asthma and AR in children with AD in a wide range of 60%-80% 1,2,5,12 . Th us, Carmi et al. 13 found associated asthma and AR in 20.3% of children with AD, while Zhao et al.
14 found both diseases associated in 49.5% of children with AD. In their study, Samochocki et al. 15 report that children with AD developed asthma and AR in 17.4% and 32.1% of cases, respectively. Our results are in accordance with these, as out of 114 children enrolled in the study, 31.6% developed asthma, 28.9% experienced symptoms of AR, and 13 children had both diseases. Regarding the severity of AD, Gustafsson et al. 2 , Ricci et al. 16 and Illi et al. 17 found that children with high severity scores were at an increased risk of developing asthma. Kobyletzki et al. 18 also found higher odds of developing asthma and AR for the moderate and severe forms of AD in comparison with the mild form of AD. Our results are slightly different from these, as we found a signifi cantly high risk of developing both diseases for the severe and moderate forms of AD, whereas 7 children with the mild form of AD also developed asthma. Th e results of various studies suggest that the early onset of AD is one of the most important risk factors for developing asthma and AR in children with AD. Kobyletzki et al. 18 also point out that the early onset was a strong risk factor for the incidence of asthma (OR 3.44) and AR. Similar results were obtained by Illi et al. 17 and Kelbore et al. 19 , who suggest that early onset, but also parental atopic history, increase the odds of developing asthma and AR. Our results are in accordance with the above; a signifi cantly increased risk of developing asthma and AR was found in children with positive heredity of atopy and in children with early onset of AD. However, the multivariate analysis with relevant factors for asthma showed that the increased absolute eosinophil count was also a very important predictor of the devel- Studies show that within the fi rst 2 to 4 years of life, children with AD and positive SPTs and specifi c IgE antibodies to food allergens and/or aeroallergens are at a higher risk of progressing into atopy [20] [21] [22] . Our results comply with this since it was found that positivity of IgE to aeroallergens and food allergens was the most signifi cant predictor of developing asthma. Th e correlation between AD and food allergies was about 30%, particularly in those children with early onset, with the severe and persistent form of AD. Whether children with IgE-mediated food allergy are at an increased risk of developing subsequent asthma and AR is unclear 11 . Early manifestation of food allergy is accompanied by a very high risk of sensitization to aeroallergens and a high risk of developing asthma and AR in children with AD 20 . Th e results obtained by Lowe et al. 21 also suggested a greater risk of asthma and AR in children with AD and sensitivity to food allergens. Our study results comply with these, since out of 38 children with sensitivity to food, 24 children developed asthma and 13 developed AR. Malmberg et al. 23 and Saarinen et al. 24 point out that children with cow's milk allergy by the age of 7 months exhibited increased airway infl ammation and bronchial responsiveness. In our study, at the fi rst visit, 51 children with AD already had episodes of bronchial obstruction and 17 of them developed sensitivity to cow's milk in early infancy. On the other hand, data reported by Gustafsson et al. 2 show that 25% of children with symptoms of food allergy before 36 months of age failed to develop asthma or AR. Our results are diff erent in comparison with these results, since 21% of children with AD and food allergy before 36 months of age developed asthma, and 11.41% of them developed AR. In their study on the signifi cance of delayed solid food introduction to prevent the risk of developing asthma and AR in children with AD, Zutavern et al. 25 showed that the delayed introduction of solid food was not associated with decreased odds for developing asthma, AR or sensitization to food or inhalant allergens. Similarly, we did not fi nd an increased risk of developing asthma or AR in children who were introduced solid food before 6 months of age. Opinions on the actual role of aeroallergens in the pathophysiology of AD are still divided, although research shows that at least one aeroallergen is present in 40%-50% of children with AD positivity and these children more often have associated asthma and AR 26, 27 . In our study, 18 children developed asthma and almost an equal number developed AR out of 23 children with sensitivity to aeroallergens. It was observed that sensitivity to aeroallergens (positive SPTs, specifi c IgE) was a signifi cant risk factor for development of asthma and AR. Also, in their studies, Jedrychowski et al. 28 and Arruda et al. 29 suggest that the presence of sensitivity to aeroallergens was a signifi cant risk factor for developing asthma in children with AD. Th ey also examined the eff ects of exposure to tobacco smoke in children with AD and emphasize that it was associated with the risk of developing asthma. However, in the study by Gustafsson et al. 2 on the eff ects of exposure to tobacco smoke or presence of furry animals at home, the increased risk of developing respiratory allergies was not observed. Our data are similar, and somewhat expected. It seems that families with atopic problems avoid keeping furry animals and smoking in comparison with the general population. Th e parents who deal with their children's atopy are likely to eliminate the risk factors which may worsen AD and may contribute to the development of respiratory allergy. Kotrulja et al. 30 emphasize that it is essential for parents to be informed and educated on AD, treatments and risk factors in order to improve their children's and the whole family's quality of life, but also to better monitor the disease.
Conclusion
Our study confi rmed that the increased risk of developing respiratory allergy among children with AD, with the increased absolute eosinophil count, positive specifi c IgE to aeroallergens and food allergens, family history of AD, and early onset of AD are the best predictors. Identifi cation of risk factors will enable us to closely monitor and improve the treatment of children with AD in order to reduce the severity of disease and prevent the possible manifestation of respiratory allergy.
